Jennifer L Antholz Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 510 Bradford St, Seward, NE 68434 Phone: 402-484-0595 Fax: 402-484-6306 |
Jack Everie Carlson, LIMHP LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 459 S 6th St, Blue Valley Behavioral Health, Seward, NE 68434 Phone: 402-643-3343 Fax: 402-643-4048 |
Mrs. Kelsey E Koranda, LMHP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 217 N 1st St, Seward, NE 68434 Phone: 402-560-4528 |
Cara K Kroeker, LIMHP, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2055 Meadow Ln Apt 7, Seward, NE 68434 Phone: 402-366-5155 |
Barbara Rebentisch, LIMHP, LMHP, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 905 Main St, Seward, NE 68434 Phone: 402-641-5313 Fax: 402-646-2045 |
Dustana Mencl, PLMHP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 122 S 4th St, Seward, NE 68434 Phone: 402-643-4954 |
News Archive
People under age 40 who are diagnosed with Type 2 diabetes are more likely to have or die from cardiovascular disease than those of similar age without diabetes and the excess risks were more pronounced in younger women, according to new research in the American Heart Association's journal Circulation.
CAS Medical Systems, Inc. today announced that three scientific abstracts demonstrating the use of the Company's FORE-SIGHT Absolute Oximeter were presented at the annual conference of the American Academy of Pediatrics in San Francisco, CA, October 2-5, 2010.
Trekking and mountain climbing are quickly growing in popularity, but.one of the challenges that climbers face is acute mountain sickness (AMS). Previous studies have shown that ibuprofen is an effective way to reduce the risk of AMS.
A national group of researchers, medical bodies and charities, led by The University of Manchester is looking for help in setting the top priorities for fighting womb cancer, with a survey launched today (23 March 2015).
AVACEN Medical announced today that it has launched a $2 million campaign on Crowdfunder.com to support further company clinical trials and FDA applications.
› Verified 8 days ago